Markel Group Inc. Increases Position in HCA Healthcare, Inc. (NYSE:HCA)

Markel Group Inc. increased its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 45.1% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 50,930 shares of the company's stock after acquiring an additional 15,825 shares during the quarter. Markel Group Inc.'s holdings in HCA Healthcare were worth $20,699,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in the company. Bangor Savings Bank boosted its holdings in shares of HCA Healthcare by 112.5% during the second quarter. Bangor Savings Bank now owns 85 shares of the company's stock worth $27,000 after purchasing an additional 45 shares during the period. MFA Wealth Advisors LLC purchased a new stake in shares of HCA Healthcare during the second quarter worth $27,000. Unique Wealth Strategies LLC purchased a new stake in shares of HCA Healthcare during the 2nd quarter worth about $28,000. GPS Wealth Strategies Group LLC raised its position in HCA Healthcare by 284.0% during the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company's stock valued at $31,000 after acquiring an additional 71 shares in the last quarter. Finally, Benjamin F. Edwards & Company Inc. acquired a new position in shares of HCA Healthcare during the 2nd quarter worth $33,000. 62.73% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

HCA has been the topic of a number of recent analyst reports. Royal Bank of Canada lifted their price target on shares of HCA Healthcare from $378.00 to $405.00 and gave the company an "outperform" rating in a research report on Friday, August 23rd. StockNews.com cut HCA Healthcare from a "strong-buy" rating to a "buy" rating in a report on Monday, November 4th. Truist Financial raised their price objective on shares of HCA Healthcare from $390.00 to $430.00 and gave the company a "buy" rating in a research report on Monday, August 19th. Barclays reduced their target price on shares of HCA Healthcare from $396.00 to $392.00 and set an "overweight" rating on the stock in a research note on Friday. Finally, Leerink Partners increased their price target on shares of HCA Healthcare from $367.00 to $396.00 and gave the company an "outperform" rating in a research report on Wednesday, July 24th. Five research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $379.17.

Insider Activity at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 8,358 shares of the business's stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the sale, the executive vice president now directly owns 29,678 shares of the company's stock, valued at $11,438,494.76. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 1.60% of the stock is owned by insiders.

HCA Healthcare Stock Performance

NYSE:HCA traded down $1.87 during mid-day trading on Friday, reaching $354.16. 1,252,655 shares of the company's stock were exchanged, compared to its average volume of 1,542,979. The firm has a market capitalization of $89.71 billion, a PE ratio of 15.90, a price-to-earnings-growth ratio of 1.34 and a beta of 1.68. HCA Healthcare, Inc. has a one year low of $226.48 and a one year high of $417.14. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. The business's fifty day simple moving average is $389.61 and its two-hundred day simple moving average is $356.03.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be paid a $0.66 dividend. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 annualized dividend and a dividend yield of 0.75%. HCA Healthcare's payout ratio is 11.85%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.